| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/14/2011 | EP1405906B1 Schwann cells originating from bone marrow stromal cells |
| 09/14/2011 | EP1262555B1 Protein hollow nano particles, transporter with the use of the same and method of introducing substance into cells |
| 09/14/2011 | EP1257264B1 Estrogen receptor modulators |
| 09/14/2011 | EP1237582B1 Methods for introducing genes into mammalian subjects |
| 09/14/2011 | CN1872879B Anagonism active polypeptide of CXCR4 acceptor from inflammation protein of virus macrophage |
| 09/14/2011 | CN1827135B Compound Chinese medicine for resisting-senility and prolonging life |
| 09/14/2011 | CN1642551B Inhibitors of histone deacetylase |
| 09/14/2011 | CN102186872A Anti-xdr-tb agent, anti-mdr-tb agent, and combined anti-tuberculous agent |
| 09/14/2011 | CN102186850A Phenanthroindolizidine derivative and nfkb inhibitor containing same as active ingredient |
| 09/14/2011 | CN102186849A Phenanthroindolizidine compound and nf?b inhibitor containing same as active ingredient |
| 09/14/2011 | CN102186848A Benzoquinoline inhibitors of vesicular monoamine transporter 2 |
| 09/14/2011 | CN102186845A S1p receptors modulators and their use thereof |
| 09/14/2011 | CN102186841A 2-aminopyridin-4-one and 2-aminopyridine derivative both having bace1-inhibiting activity |
| 09/14/2011 | CN102186803A Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitors |
| 09/14/2011 | CN102186467A Pharmaceutical compositions with attenuated release of phenolic opioids |
| 09/14/2011 | CN102180944A Remodeling and glycoconjugation of peptides |
| 09/14/2011 | CN102178917A Chinese medicinal composition for treating qi activity wallop |
| 09/14/2011 | CN102178911A Chinese medicine preparation used for dispelling wind and eliminating dampness, dredging collaterals and stopping pains for people with deficiency of yang and phlegm dampness constitution, and preparation method and application of preparation |
| 09/14/2011 | CN102178910A Chinese medicine preparation for relieving symptoms of people with blood stasis, and preparation method and application thereof |
| 09/14/2011 | CN102178871A Traditional Chinese medicine preparation used for relieving bursting pain symptoms at two rib parts of people with qi depression and phlegm dampness constitution and preparation method and application |
| 09/14/2011 | CN102178870A Chinese medicinal preparation for promoting qi circulation, promoting blood circulation, softening hard mass and eliminating stagnation for people with qi-depression and phlegm-damp physique, preparation method thereof and application thereof |
| 09/14/2011 | CN102178866A Chinese medicinal preparation for dispelling damp, promoting blood circulation, softening hard mass and eliminating stagnation for people with qi-depression and blood-stagnation physique, preparation method thereof and application thereof |
| 09/14/2011 | CN102178847A Vacuum freeze-drying processing method of dendrobium officinale |
| 09/14/2011 | CN102178840A Chinese medicinal preparation for relieving body fluid deficiency for people with yin-deficiency physique, preparation method thereof and application thereof |
| 09/14/2011 | CN102178830A Formula for pathogenic fire reducing effervescent tablets and preparation method thereof |
| 09/14/2011 | CN102178817A Chinese medicinal composition for treating multiple lipomas |
| 09/14/2011 | CN102178756A Oral liquid for treating high altitude disease (HAD) and preparation method thereof |
| 09/14/2011 | CN102178753A Medicinal preparation with effects of clearing heat, purging intense heat, detonicating, eliminating blood stasis, cooling blood and stopping bleeding |
| 09/14/2011 | CN102178744A Formula of effervescent tablets for regulating flow of vital energy and preparation method thereof |
| 09/14/2011 | CN102178743A Formula of effervescent tablets for detoxifying and preparation method thereof |
| 09/14/2011 | CN102178699A Preparation for enhancing human immunity and promoting growth and development |
| 09/14/2011 | CN102178696A Method for preparing amino acid chelated full-nutritional pearls |
| 09/14/2011 | CN101785848B Traditional Chinese medicine combination and preparation method thereof for hypochondriac pain treatment |
| 09/14/2011 | CN101785819B Traditional Chinese medicine combination and preparation method thereof for hydrothorax treatment |
| 09/14/2011 | CN101757451B Natural plant preparation for promoting nutrition rehabilitation of mucous membrane of animal and preparing method thereof |
| 09/14/2011 | CN101624376B Substituted hydrazide compound and application thereof |
| 09/14/2011 | CN101579352B Application of polysaccharide component of longan pulp in pharmacy |
| 09/14/2011 | CN101506170B 6-(heterocycle-substituted benzyl)-4-oxoquinoline compound and use of the same as HIV integrase inhibitor |
| 09/14/2011 | CN101455844B PEG-erythrocyte-stimulating factor and preparation method and use thereof |
| 09/14/2011 | CN101087605B Medicine for the treatment or prevention of fibrotic diseases |
| 09/13/2011 | USRE42700 Induction of apoptosis in cancer cells |
| 09/13/2011 | US8019557 Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same |
| 09/13/2011 | US8017726 Anti-inflammatory compounds and uses thereof |
| 09/13/2011 | US8017652 Activators of peroxisome proliferator-activated receptors |
| 09/13/2011 | US8017643 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 09/13/2011 | US8017628 Pharmaceutically active sulfonyl hydrazide derivatives |
| 09/13/2011 | US8017596 Phosphonates useful as modulators of T-γ-9-δ-2 activity |
| 09/13/2011 | US8017587 2-O- (β-D-glucopyranosyl) ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it |
| 09/13/2011 | US8017585 CXCR4 antagonist and use thereof |
| 09/13/2011 | US8017125 Copolymers for suppression of autoimmune diseases, and methods of use |
| 09/13/2011 | CA2639407C Pharmaceutical compositions comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid or a pharmaceutically acceptable salt thereof |
| 09/13/2011 | CA2522318C Drug for preventing or treating angiogenic eye diseases |
| 09/13/2011 | CA2492410C Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 09/13/2011 | CA2486869C Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 09/13/2011 | CA2469075C Pyrrolidine derivatives as prostaglandin modulators |
| 09/13/2011 | CA2452606C Tetrahydroquinoline derivatives |
| 09/13/2011 | CA2440238C Novel amines as histamine-3 receptor ligands and their therapeutic applications |
| 09/13/2011 | CA2407573C Imidazopyridine derivatives |
| 09/13/2011 | CA2378187C Methods for treating therapy-resistant tumors |
| 09/13/2011 | CA2351735C Engineered cytotoxic ribonuclease |
| 09/13/2011 | CA2334119C Pharmaceutical composition with tumor necrosis factor a and 2-methoxyestrone-3-o-sulphamate for inhibition of estrone sulphatase |
| 09/13/2011 | CA2327587C Methods for treatment of haemophilia a patients using human anti-human fviii antibodies |
| 09/13/2011 | CA2250792C Cocoa extract compounds and methods for making and using the same |
| 09/09/2011 | WO2011109298A2 Therapeutic dll4 binding proteins |
| 09/09/2011 | WO2011109012A1 Use of 2'-deoxy-4'-thiocytidine and its analogues as dna hypomethylating anticancer agents |
| 09/09/2011 | WO2011108762A1 Prophylactic and/or ameliorating agent for insulin resistance |
| 09/09/2011 | WO2011108692A1 Agent for preventing muscular atrophy |
| 09/09/2011 | WO2011108690A1 Alkylamine derivative |
| 09/09/2011 | WO2011108624A1 Polymer of nitrogen-containing compound, method for producing same, and gene transfer agent |
| 09/09/2011 | WO2011108499A1 Osteoblast differentiation promoter, pharmaceutical composition for promoting ossification, and health food containing auraptene analog as active ingredient |
| 09/09/2011 | WO2011108425A1 Immunomodulator preparation method and immunomodulator |
| 09/09/2011 | WO2011108275A1 Immunoglobulin a secretion promoter |
| 09/09/2011 | CA2791631A1 Therapeutic dll4 binding proteins |
| 09/09/2011 | CA2791174A1 Alkylamine derivative |
| 09/09/2011 | CA2789073A1 Agent for preventing muscular atrophy |
| 09/08/2011 | US20110218343 Small molecule inhibitors of rotamase enzyme activity |
| 09/08/2011 | US20110218237 Compound and composition and their uses thereof |
| 09/08/2011 | US20110218236 Compound and composition and their uses thereof |
| 09/08/2011 | US20110218208 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases |
| 09/08/2011 | US20110218189 PYRROLO[2,3-d]PYRIMIDIN-2-YL-AMINE DERIVATIVES AS PKC-THETA INHIBITORS |
| 09/08/2011 | US20110218187 Inhibitors of tyrosine kinases |
| 09/08/2011 | US20110218181 Formulations of deoxycholic acid and salts thereof |
| 09/08/2011 | US20110218160 Arylalkylamine compound and process for preparing the same |
| 09/08/2011 | US20110218143 Compositions and methods for tissue repair |
| 09/08/2011 | US20110218107 Use of Propineb for Physiological Curative Treatment Under Zinc Deficiency |
| 09/08/2011 | US20110217753 Inhibitors of extracellular proteases |
| 09/08/2011 | US20110217389 Methods for treating heat stress and related compositions |
| 09/08/2011 | US20110217381 Pharmaceutical compositions |
| 09/08/2011 | US20110217342 Flashmelt oral dosage formulation |
| 09/08/2011 | US20110217337 Bioactive agent for bone tissue engineering |
| 09/08/2011 | US20110217289 Melt-Coated Dosage Forms |
| 09/08/2011 | US20110217283 Stable galenic freeze-dried pharmaceutical preparation of recombinant carbohydrate-binding polypeptides |
| 09/08/2011 | US20110217277 Drug or dermatological composition containing an avocado peptide extract for treating and preventing pruritus |
| 09/08/2011 | US20110217272 Treatment of radiation injury using placental stem cells |
| 09/08/2011 | US20110217271 Treatment of diseases or disorders using placental stem cells |
| 09/08/2011 | US20110217255 Block copolymers and their use |
| 09/08/2011 | US20110217237 Therapeutic dll4 binding proteins |
| 09/08/2011 | US20110217233 Modulation of intracellular signaling |
| 09/08/2011 | US20110217232 Method for Determination of the Responsiveness of an Individual to Misletoe Lectin |
| 09/07/2011 | EP2363472A1 Method for enhancing expression of recombinant protein |